THOMAS SHRADER joined Harris Nesbitt Gerard in 2001 (then Gerard Klauer
Mattison) as a Research Analyst in the Healthcare Group, focusing on
biotechnology. Previously, he had been a Vice President of Equity
Research in Biotechnology at Tucker Anthony Sutro. His prior experience
includes research analysis at Oscar Gruss & Son and eight years as a
Professor of Biochemistry at the Albert Einstein College of Medicine. He
holds a degree in Biophysics from Johns Hopkins University and earned
his PhD in Molecular Biophysics and Biochemistry at Yale University. As
a Helen Hay Whitney Postdoctoral Fellow in Biology at the Massachusetts
Institute of Technology, he conducted research in Molecular Genetics.
A Cautious Perspective on the Biotechnology Sector
March 10, 2017
Roundtable Forum: Biotechnology
July 28, 2003